Literature DB >> 22941537

Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram.

Jia-ying Chen1, Jia-jian Chen, Ben-long Yang, Zhe-bin Liu, Xiao-yan Huang, Guang-yu Liu, Qi-xia Han, Wen-tao Yang, Zhen-zhou Shen, Zhi-min Shao, Jiong Wu.   

Abstract

We assessed the MSKCC nomogram performance in predicting SLN metastases in a Chinese breast cancer population. A new model (the SCH nomogram) was developed with clinically relevant variables and possible advantages. Data were collected from 1,545 patients who had a successful SLN biopsy between March 2005 and November 2011. We validated the MSKCC nomogram in the modeling and validation group. Clinical and pathologic features of SLN biopsy in modeling group of 1,000 patients were assessed with multivariable logistic regression to predict the presence of SLN metastasis in breast cancer. The SCH nomogram was created from the logistic regression model and subsequently applied to 545 consecutive SLN biopsies. By multivariate analysis, age, tumor size, tumor location, tumor type, and lymphovascular invasion were identified as independent predictors of SLN metastasis. The SCH nomogram was then developed using the five variables. The new model was accurate and discriminating (with an AUC of 0.7649 in the modeling group) compared to the MSKCC nomogram (with an AUC of 0.7105 in the modeling group). The area under the ROC curve for the SCH nomogram in the validation population is 0.7587. The actual probability trends for the various deciles were comparable to the predicted probabilities. The false-negative rates of the SCH nomogram were 1.67, 3.54, and 8.20 % for the predicted probability cut-off points of 5, 10, and 15 %, respectively. Compared with the MSKCC nomogram, the SCH nomogram has a better AUC with fewer variables and has lower false-negative rates for the low-probability subgroups. The SCH nomogram could serve as a more acceptable clinical tool in preoperative discussions with patients, especially very-low-risk patients. When applied to these patients, the SCH nomogram could be used to safely avoid a SLN procedure. The nomogram should be validated in various patient populations to demonstrate its reproducibility.

Entities:  

Mesh:

Year:  2012        PMID: 22941537     DOI: 10.1007/s10549-012-2219-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  21 in total

1.  Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI.

Authors:  Yuhao Dong; Qianjin Feng; Wei Yang; Zixiao Lu; Chunyan Deng; Lu Zhang; Zhouyang Lian; Jing Liu; Xiaoning Luo; Shufang Pei; Xiaokai Mo; Wenhui Huang; Changhong Liang; Bin Zhang; Shuixing Zhang
Journal:  Eur Radiol       Date:  2017-08-21       Impact factor: 5.315

2.  Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.

Authors:  Chunling Liu; Jie Ding; Karl Spuhler; Yi Gao; Mario Serrano Sosa; Meghan Moriarty; Shahid Hussain; Xiang He; Changhong Liang; Chuan Huang
Journal:  J Magn Reson Imaging       Date:  2018-09-01       Impact factor: 4.813

3.  A Model to Predict the Risk of Lymph Node Metastasis in Breast Cancer Based on Clinicopathological Characteristics.

Authors:  Wenxin Chen; Chuan Wang; Fangmeng Fu; Binglin Yang; Changming Chen; Yingming Sun
Journal:  Cancer Manag Res       Date:  2020-10-22       Impact factor: 3.989

4.  Toward Exempting from Sentinel Lymph Node Biopsy in T1 Breast Cancer Patients: A Retrospective Study.

Authors:  Guozheng Li; Jiyun Zhao; Xingda Zhang; Xin Ma; Hui Li; Yihai Chen; Lei Zhang; Xin Zhang; Jiale Wu; Xinheng Wang; Yan Zhang; Shouping Xu
Journal:  Front Surg       Date:  2022-06-28

5.  Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.

Authors:  Jia-ying Chen; Jia-jian Chen; Jing-yan Xue; Ying Chen; Guang-yu Liu; Qi-xia Han; Wen-tao Yang; Zhen-zhou Shen; Zhi-min Shao; Jiong Wu
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

6.  Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer.

Authors:  A Laws; R Cheifetz; R Warburton; C E McGahan; J S Pao; U Kuusk; C Dingee; M L Quan; E McKevitt
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

7.  Development and validation of a nomogram for prediction of lymph node metastasis in early-stage breast cancer.

Authors:  Huan Li; Lin Tang; Yajuan Chen; Ling Mao; Hui Xie; Shui Wang; Xiaoxiang Guan
Journal:  Gland Surg       Date:  2021-03

8.  A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.

Authors:  Si-Qi Qiu; Huan-Cheng Zeng; Fan Zhang; Cong Chen; Wen-He Huang; Rick G Pleijhuis; Jun-Dong Wu; Gooitzen M van Dam; Guo-Jun Zhang
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

9.  Non-invasive prediction of lymph node status for patients with early-stage invasive breast cancer based on a morphological feature from ultrasound images.

Authors:  Tao Jiang; Weiwei Su; Yanan Zhao; Qunying Li; Pintong Huang
Journal:  Quant Imaging Med Surg       Date:  2021-08

10.  Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer.

Authors:  S Majid; P-O Bendahl; L Huss; J Manjer; L Rydén; L Dihge
Journal:  BJS Open       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.